Supply of Essential Vaccines to the National Immunisation Program

A later observation replaced this one. The explorer’s totals use $52,196,580.28 from the latest observation, published 30 June 2026.

$23,100,000.00

Full reported contract value · AUD including applicable GST · 2025-07-01 to 2026-06-30

Reporting agency: Department of Health, Disability and Ageing
Reported supplier: Merck Sharpe & Dohme (AUSTRALIA) Pt
Reported ABN: 14 000 173 508. Exemption as supplied: No.
Category: Drugs and Pharmaceutical Products
Procurement method: Limited tender
Original publication: 2025-07-03 15:20:00 (ACT local time as supplied)
Amendment publication: Original notice; no amendment publication supplied
Amendment reason: Not supplied
Agency reference: 4500160465
Approach to market / standing offer: Health/22-23/12358 / SON4069568
Consultancy: No
Confidentiality as reported: Contract: Yes; outputs: No
Source observation: CN4166709 · Official weekly workbook ending 2025-07-05 · sheet “Contract Notice Export”, row 256.

The original register may now show later corrections. The card and this observation keep the saved source date.